HIV-1 GP41 neutralizing antibodies and uses thereof
The present invention discloses neutralizing antibodies and antigen binding fragments of these antibodies that specifically bind to HIV-1Env. Nucleic acids, vectors and host cells encoding these antibodies are also provided. Methods of detecting HIV-1 using these antibodies are disclosed. In additio...
Saved in:
Main Authors | , , , , , , , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
06.09.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention discloses neutralizing antibodies and antigen binding fragments of these antibodies that specifically bind to HIV-1Env. Nucleic acids, vectors and host cells encoding these antibodies are also provided. Methods of detecting HIV-1 using these antibodies are disclosed. In addition, the use of these antibodies, antigen binding fragments, nucleic acids and vectors to prevent and/or treat HIV-1 infection is disclosed.
本发明公开了特异结合HIV-1Env的中和抗体和这些抗体的抗原结合片段。还提供了编码这些抗体的核酸、载体和宿主细胞。公开了采用这些抗体检测HIV-1的方法。另外,公开了这些抗体、抗原结合片段、核酸和载体防止和/或治疗HIV-1感染的用途。 |
---|---|
Bibliography: | Application Number: CN202210669835 |